Please login to the form below

Not currently logged in
Email:
Password:

Bayer announces new leadership

New CEO and CFO will take over in 2010

Dr Marijn E Dekkers, current president and chief executive officer (CEO) of Thermo Fisher Scientific, will succeed Werner Wenning as CEO at Bayer from October 1 2010. Dekkers will join the Bayer management board on January 1 2010. He will also serve as interim CEO of Bayer HealthCare, succeeding Arthur J Higgins who will leave the company during the first half of 2010 for personal reasons.

Werner Baumann will become chief financial officer (CFO) following the annual stockholders' meeting on April 30 2010, when the present CFO, Klaus Kühn, takes early retirement. Baumann is currently a member of both the management board and executive committee of Bayer HealthCare, and will also join the Bayer management board on January 1 2010.

Werner Wenning will extend his contract of service to September 30 2010.

"Mr Wenning has very successfully steered our company for the past seven years. We are grateful to him for consenting to extend his contract of service, thereby ensuring both continuity and an adequate period of transition in these economically difficult times," stated Dr Manfred Schneider, chairman of the Bayer supervisory board. "The supervisory board believes that, in Dr Dekkers, it has found a highly qualified successor to steer the fortunes of our company. His international experience, goal-oriented approach and proven management skills are very convincing qualities."

16th September 2009

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Caudex Medical

Caudex Medical work as strategic partners with the global healthcare community driving dynamic medical communications. We breathe life into science...

Latest intelligence

Free White Paper: Customer Experience for Pharma
To learn why an effective customer experience strategy is vital for pharma, download our white paper “Customer experience for pharma” to learn more....
How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....